Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1201 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Aurobindo Pharma obtains FDA final approval for MDD drug

Venlafaxine Hydrochloride Extended-release capsules 37.5mg, 75mg and 150mg are generic equivalent of Wyeth Pharmaceuticals’ Effexor XR capsules 37.5mg, 75mg and 150mg. Aurobindo Pharma received tentative approval from the

FDA issues CRL to Eli Lilly EPI drug

Liprotamase is an oral, non-porcine (not made from harvesting the pancreas of pigs), biotechnology-derived, pancreatic enzyme replacement therapy (PERT) developed to treat patients with EPI associated with cystic

Amylin Pharma Q1 revenues fall

The company has posted a net loss of $37.32m for the first quarter 2011, or $0.26 loss per diluted share, compared to net loss of $38.2m, or $0.27

UCB research links RLS to CV disease

The study matched the US medical records of 3,485 RLS patients to those of 3,485 patients without RLS. The most frequent CV diagnoses observed were hypertension (48%), cardiac